CBUS 3.59 Cibus, Inc.
| Range: | 2.858-23.18 | Vol Avg: | 200432 | Last Div: | 0 | Changes: | 0.13 |
| Beta: | 1.82 | Cap: | 0.11B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jul 20 2017 | Empoloyees: | 183 | ||
| CUSIP: | 17166A101 | CIK: | 0001705843 | ISIN: | US17166A1016 | Country: | US |
| CEO: | Mr. Rory Balfour Riggs M.B.A. | Website: | https://www.cibus.com | ||||
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
Stock Details
CBUS 21
Canaccord Genuity Reiterates Buy Rating on Cibus (CBUS)
Austin Moeller·Fri Aug 23 2024
Canaccord Genuity
CBUS 25
Cibus initiated with a Buy at Alliance Global Partners
Matthew Venezia·Mon Jul 29 2024
Industrial Alliance Securities
CBUS 22
Cibus assumed with a Buy at Canaccord
Austin Moeller·Fri Jul 19 2024
Canaccord Genuity
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow